Zobrazeno 1 - 10
of 24
pro vyhledávání: '"carbapenem-resistant enterobacteria"'
Autor:
Oscar A. Fernández-García, María F. González-Lara, Marco Villanueva-Reza, Nereyda de-León-Cividanes, Luis F. Xancal-Salvador, Verónica Esteban-Kenel, Ayleen Cárdenas-Ochoa, Axel Cervantes-Sánchez, Areli Martínez-Gamboa, Eric Ochoa-Hein, Arturo Galindo-Fraga, Miriam Bobadilla-del-Valle, José Sifuentes-Osornio, Alfredo Ponce-de-León
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT Emergency department areas were repurposed as intensive care units (ICUs) for patients with acute respiratory distress syndrome during the initial months of the coronavirus disease 2019 (COVID-19) pandemic. We describe an outbreak of New Del
Externí odkaz:
https://doaj.org/article/65957b7f407047409251a3396db773a2
Autor:
Paola Bocanegra-Ibarias, Adrián Camacho-Ortiz, Elvira Garza-González, Samantha Flores-Treviño, Hyojin Kim, Eduardo Perez-Alba
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 23, Iss , Pp 417-419 (2020)
Objectives: We report the successful treatment of a bloodstream infection caused by Klebsiella pneumoniae harbouring NDM-1 using aztreonam-ceftazidime-avibactam in a neutropenic patient in whom colistin and meropenem therapy had previously failed. Me
Externí odkaz:
https://doaj.org/article/8fcbf7960df04966a931ec21457fe344
Publikováno v:
Фармакоэкономика, Vol 12, Iss 2, Pp 72-84 (2019)
Aim: to assess the economic outcomes of using ceftazidime + avibactam (compared with the recommended treatments) in adult patients with sepsis caused by carbapenem-resistant enterobacteria.Methods. The economic assessment was made using the cost-effe
Externí odkaz:
https://doaj.org/article/e77b644578b8405bbc3c844dd2de146e
Autor:
Celeste Moya, Sergi Maicas
Publikováno v:
Proceedings, Vol 66, Iss 1, p 11 (2020)
The enterobacteria that produce β-lactamases are the main focus of infections in the healthcare environment. This is due to the difficulty they present in terms of treatment, their ease of transmission, and the impact they represent at the economic
Externí odkaz:
https://doaj.org/article/16cdfed145e44529805151e8822f57b4
Publikováno v:
Фармакоэкономика, Vol 12, Iss 2, Pp 72-84 (2019)
Aim: to assess the economic outcomes of using ceftazidime + avibactam (compared with the recommended treatments) in adult patients with sepsis caused by carbapenem-resistant enterobacteria. Methods. The economic assessment was made using the cost-eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0a9bbd03176d0dc9b9cff589f4ae335
https://www.pharmacoeconomics.ru/jour/article/view/289
https://www.pharmacoeconomics.ru/jour/article/view/289
Autor:
Füsun Zeynep Akçam
Publikováno v:
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Vol 24, Iss 2, Pp 75-86 (2019)
Carbapenem resistant Enterobacteriaceae (CRE) cause infections with limited treatment options and serious mortality and morbidity. Currently, colistin, tigecycline and phosphomycin and their combination with each other or with carbapenems are used in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eb2a3fa1b1a79115f9de979d6950dce
http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2019-24-02-075-086.pdf
http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2019-24-02-075-086.pdf
Autor:
Sergi Maicas, Celeste Moya
Publikováno v:
Proceedings, Vol 66, Iss 11, p 11 (2020)
The enterobacteria that produce β-lactamases are the main focus of infections in the healthcare environment. This is due to the difficulty they present in terms of treatment, their ease of transmission, and the impact they represent at the economic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::949d82266086e007fcd5b29c75706c4b
https://doi.org/10.3390/proceedings2020066011
https://doi.org/10.3390/proceedings2020066011
Autor:
Jurić, Ivana
Enterobakterije otporne na karbapeneme (eng. Carbapenem-Resistant Enterobacteriaceae, CRE) su razvile sposobnost stvaranja beta-laktamaza KPC, VIM, NDM i OXA-48 zbog sve veće uporabe karbapenema u kliničkoj praksi te predstavljaju veliku opasnost z
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3908::54937214d3800c34e2dad27b0fcd745f
https://repozitorij.pmf.unizg.hr/islandora/object/pmf:8322/datastream/PDF
https://repozitorij.pmf.unizg.hr/islandora/object/pmf:8322/datastream/PDF
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.